Abstract:
Background: The World Health Organization recommends molecular tests Polymerase
Chain Reaction (PCR) to the diagnosis of coronavirus disease of 2019 (COVID-19),
which detect the Severe Acute Respiratory Syndrome (SARS-Coronavirus 2) virus RNA.
However, these tests are expensive and give a high negative result. There were urgent
medical and public health needs for early diagnosis and treatment to minimize the
spread of COVID-19. This review aimed to summarize known to date information about
the latest research progress of the sensitivity and specificity of rapid combined IgM/IgG
antibody test to diagnose the pandemic novel coronavirus disease of 2019 (COVID-19).